Asa Abeliovich

Company: Leal Therapeutics

Job title: Chief Executive Officer & Founder

Seminars:

Workshop A: Pioneering Modalities for ALS: Unpacking the Gene Therapy Toolbox & Beyond 9:00 am

From gene editing and augmentation to emerging delivery systems and knockdown strategies, the session will provide a comprehensive exploration of the gene therapy landscape. Participants will discuss which technologies are best suited for targeting specific ALS mutations, the challenges of sporadic versus hereditary forms, and the broader application of current platforms. By analyzing both successes…Read more

day: Pre Conference Day Workshop Track A